Thyrotoxicosis developing during cyclophosphamide therapy.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000378:metabolism; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D006111:Graves Disease / Q000139:chemically induced*; D006801:Humans; D007165:Immunosuppression Therapy; D008135:Long-Acting Thyroid Stimulator / Q000032:analysis; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D013972:Thyrotropin / Q000378:metabolism
D003520:Cyclophosphamide; D013972:Thyrotropin; D008135:Long-Acting Thyroid Stimulator